Next Article in Journal
The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Previous Article in Journal
Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches
 
 
Article

Article Versions Notes

Pharmaceuticals 2021, 14(3), 214; https://doi.org/10.3390/ph14030214
Action Date Notes Link
article pdf uploaded. 4 March 2021 13:28 CET Version of Record https://www.mdpi.com/1424-8247/14/3/214/pdf-vor
article supplementary file uploaded. 4 March 2021 13:28 CET - https://www.mdpi.com/1424-8247/14/3/214#supplementary
article xml file uploaded 15 March 2021 11:03 CET Original file -
article xml uploaded. 15 March 2021 11:03 CET Update https://www.mdpi.com/1424-8247/14/3/214/xml
article pdf uploaded. 15 March 2021 11:03 CET Updated version of record https://www.mdpi.com/1424-8247/14/3/214/pdf
article html file updated 15 March 2021 11:04 CET Original file -
article html file updated 25 July 2022 06:05 CEST Update https://www.mdpi.com/1424-8247/14/3/214/html
Back to TopTop